FDA workshop on therapies for rare patient subsets

FDA will hold a public workshop on Dec. 12 to discuss approaches to evaluate precision therapies targeting subsets of patients with rare molecular characteristics. The Center for Translational and Regulatory Sciences at the University of Virginia will co-sponsor the workshop, entitled "Developing and Using Precision Therapies in the 'Omics' Era: Generating and Interpreting Evidence for Rare Subsets." ...